Metal Shards Found In Heart Meds

Medicine pills and syringe on table with brown bottle
Photo: Adul10 / Shutterstock

A single batch of a common blood pressure pill is being pulled from shelves nationwide because it may contain tiny bits of metal sharp enough to cut you from the inside.

Story Snapshot

  • Breckenridge Pharmaceutical issued a voluntary nationwide recall of one lot of Propranolol Hydrochloride Extended-Release Capsules, 60 mg, over potential metal contamination.
  • The affected lot carries NDC 51991-817-01, lot number PK25110035, and an expiration date of May 2029, sold in 100-count bottles.
  • The company says the risk is lacerations to the mouth, esophagus, stomach, or intestines from accidental metal fragments.
  • The lot shipped to pharmacies and wholesalers nationwide between October 26 and November 4, 2026.
  • No injuries or adverse events had been reported as of the announcement.

What The Recall Notice Actually Says

Breckenridge Pharmaceutical announced on November 16, 2026, that it is voluntarily recalling one lot of its propranolol capsules, a drug widely prescribed for high blood pressure and heart rhythm problems. The company said the move is a precaution tied to possible metal contamination found during production, not a confirmed defect in every bottle sold under that lot number.

The recalled product is easy to identify. It comes in 100-count bottles labeled with NDC number 51991-817-01, lot number PK25110035, and an expiration date of May 2029. Anyone holding a bottle matching those details is being told to stop taking the pills and check with a pharmacist or doctor before doing anything else.

Why A Little Metal Can Mean A Lot Of Danger

Breckenridge explained the medical concern in blunt terms. The company said using capsules from the affected lot “could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine”. That is medical language for internal cuts, the kind of injury nobody wants from a pill meant to calm their heart, not harm their gut.

The contamination trail leads back to shared raw material. Breckenridge said the recalled lot used intermediate material suspected to be the source of metal contamination already identified in a separate batch that never reached the market. In plain terms, the company caught a problem upstream and is now recalling anything downstream that touched the same suspect material.

How Far The Pills Traveled Before Anyone Noticed

This was not a local problem. Breckenridge reported the capsules went out to wholesalers and pharmacies across the entire country between October 26 and November 4, 2026. That ten-day shipping window means the bottles could be sitting on shelves or in medicine cabinets in nearly any state, which is exactly why the company chose a nationwide recall instead of a limited regional pull.

Adare Pharma Solutions manufactured the product for Breckenridge, a detail that matters for anyone tracking where quality control broke down. Drug recalls almost always start with the manufacturer or label holder spotting a problem internally, long before regulators or the public ever hear about it. This case follows that same pattern.

What Patients And Pharmacies Are Being Told To Do

The instructions are straightforward. Patients with the affected lot should stop using it immediately and call their doctor or pharmacist for a replacement prescription. Anyone with unused capsules is told to return them to the pharmacy rather than throw them away or keep taking them. Pharmacies and distributors nationwide have also been told to check their inventory against the specific lot number.

It is worth remembering that this is a prescription heart medication, and stopping blood pressure pills suddenly carries its own risks. That is why the company is steering people toward a doctor-managed swap rather than simply telling patients to quit cold turkey. Getting a same-drug refill from a different, unaffected lot keeps treatment on track while the recalled bottles get pulled.

No Reported Injuries Yet, But The Caution Stands

As of the announcement, no adverse events or injuries tied to the recalled lot had been reported. That is a genuinely good sign, but it does not erase the reason for the recall. Drug makers are expected to act on a credible risk before anyone gets hurt, not after, and pulling product off shelves before an injury happens is the system working the way it should.

Federal recall guidance treats foreign material like this as a serious enough concern to justify swift action, even when a company cannot yet say how widespread the problem is. That is the standard this recall appears to follow: identify a credible risk tied to a specific lot, act fast, and let patients and pharmacists sort out replacements through normal medical channels.

Sources:

washingtontimes.com, prnewswire.com, kmbc.com, wtsp.com, kbtx.com, houstonchronicle.com

© standardheadlines.com 2026. All rights reserved.